Literature DB >> 22981335

Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: their Cu-mediated synthesis and evaluation as false positives in a reporter gene assay.

Ali Nakhi1, Md Shafiqur Rahman, Ravada Kishore, Chandana Lakshmi T Meda, Girdhar Singh Deora, Kishore V L Parsa, Manojit Pal.   

Abstract

2-Substituted pyrrolo[2,3-b]quinoxalines having free NH were prepared directly from 3-alkynyl-2-chloroquinoxalines in a single pot by using readily available and inexpensive methane sulfonamide (or p-toluene sulfonamide) as an ammonia surrogate. The reaction proceeded in the presence of Cu(OAc)(2) affording the desired product in moderate yield. The crystal structure analysis of a representative compound and its supramolecular interactions are presented. Some of the compounds synthesized exhibited inhibitory activities against luciferase that was supported by the predictive binding mode of these compounds with luciferase enzyme through molecular docking studies. The key observations disclosed here can alert users of luciferase reporter gene assays for possible false positive results due to the direct inhibition of luciferase.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981335     DOI: 10.1016/j.bmcl.2012.08.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Identification of 2-Benzylidene-tetralone Derivatives as Highly Potent and Reversible Firefly Luciferase Inhibitors.

Authors:  Yunzhi Li; Chaoying Jin; Huiying Xu; Weijian Wu; Youqiao Wang; Jiaxin Wu; Tingyu Liu; Guohui Wan; Xin Yue; Xianzhang Bu
Journal:  ACS Med Chem Lett       Date:  2022-01-20       Impact factor: 4.345

2.  One-pot synthesis of biologically active 1,2,3-trisubstituted pyrrolo[2,3-b]quinoxalines through a palladium-catalyzed reaction with internal alkyne moieties.

Authors:  Ali Keivanloo; Tayebeh Besharati-Seidani; Babak Kaboudin; Akihiro Yoshida; Tsutomu Yokomatsu
Journal:  Mol Divers       Date:  2018-06-16       Impact factor: 2.943

3.  Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays.

Authors:  Xin Zeng; Robert Kirkpatrick; Glenn Hofmann; Didier Grillot; Valerie Linhart; Fabrice Viviani; Joseph Marino; Joseph Boyer; Taylor L Graham; Quinn Lu; Zining Wu; Andrew Benowitz; Rick Cousins
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

4.  Route to Benzimidazol-2-ones via Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating Hypoactive Sexual Desire Disorder in Women and Marine Natural Product Hunanamycin Analogue.

Authors:  Rahul D Shingare; Akshay S Kulkarni; Revannath L Sutar; D Srinivasa Reddy
Journal:  ACS Omega       Date:  2017-08-29

5.  Construction of a novel quinoxaline as a new class of Nrf2 activator.

Authors:  Murugesh Kandasamy; Kit-Kay Mak; Thangaraj Devadoss; Punniyakoti Veeraveedu Thanikachalam; Raghavendra Sakirolla; Hira Choudhury; Mallikarjuna Rao Pichika
Journal:  BMC Chem       Date:  2019-09-24

6.  Pyrrolo[2,3-b]quinoxalines in attenuating cytokine storm in COVID-19: their sonochemical synthesis and in silico / in vitro assessment.

Authors:  Raviteja Chemboli; Ravikumar Kapavarapu; K Deepti; K R S Prasad; Alugubelli Gopi Reddy; A V D Nagendra Kumar; Mandava Venkata Basaveswara Rao; Manojit Pal
Journal:  J Mol Struct       Date:  2021-01-03       Impact factor: 3.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.